Liver transplantation for the sequelae of intra‐operative bile duct injury  by De Santibañes, E. et al.
111
Liver transplantation for the sequelae of 
intra-operative bile duct injury
E de Santibañes, J Pekolj, L McCormack, J Nefa, J Mattera, J Sívori, C Bonofiglio,
A Gadano and M Ciardullo
Hepato Bilio Pancreatic Surgery and Liver Transplant Unit, General Surgery Service, Hospital Italiano, Buenos Aires, Argentina
Background
Intra-operative bile duct injuries (IBDI) are potentially
severe complications of the treatment of benign condi-
tions, with unpredictable long-term results. Multiple
procedures are frequently needed to correct these com-
plications . In spite of the application of these procedures,
patients with severe injuries can develop irreversible liver
disease. Liver transplantation (LT) is currently the only
treatment available for such patients, but little information
has been published concerning the results of LT.
Methods
Eight patients with LT for end-stage liver disease for IBDI
were studied retrospectively. They had failure of multiple
previous treatments and experienced recurrent episodes
of cholangitis , oesophageal variceal bleeding, severe
pruritus, refractory ascites and spontaneous peritonitis.
Results
Mean recipient hepatectomy time was of 243 minutes
(range 140–295 min), the complete procedure averages
545 minutes (260–720) and intraoperative red-blood-cell s
consumption was 6.5 units (1–7). One patient required
reoperation due to perforation of a Roux-en-Y loop, and
three developed minor complications (2 wound infections,
1 inguinal lymphocele). One patient died due to nosocomial
pneumonia (mortality rate 12.5%). One patient required
retransplantation due to delayed hepatic artery thrombosis.
At follow-up 75% of patients are alive with normal graft
function and an excellent quality of life.
Conclusions
LT represents a safe curative treatment for end-stage liver
disease after IBDI, albeit a major undertaking in the
context of a surgical complication in the treatment of
benign disease. The complications of the surgical proce-
dure and the long-standing immunosupression impart a
high cost for resolutions of these sequelae but LT repre-
sents the only long-term effective treatment for these
selected patients.
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Introduction
Intra-operative bile duct injuries (IBDI) usually occur in
young patients during surgical treatment of benign diseases
and represent potentially severe complications with unpre-
dictable long-term results [1–3]. Multiple procedures are
frequently needed to correct these complications. In recent
years, endoscopic and percutaneous procedures have been
useful for resolving biliary obstructive complications, pro-
longing survival and optimising the patient’s condition
before receiving definitive treatment [4–6].
Despite application of these procedures, patients with
severe injuries develop irreversible liver disease. Chronic
cholestasis, recurrent cholangitis and progressive liver
fibrosis leading to portal hypertension are the main prob-
lems that lead to ill health and premature death. These
patients have also refractory pruritus and disabling mal-
nutrition, with multiple hospital admissions and a poor
quality of life [2, 6, 7]. Liver transplantation (LT) is
currently the only treatment available for such patients.
However, little information has been published in the
international literature concerning LT in patients with pre-
vious IBDI since the beginning of the liver transplantation
programmes [8–11]. This study reports our experience with
LT as definitive therapy for 8 patients with end-stage liver
disease secondary to IBDI.
Patients and methods
Between January 1988 and July 1998, 14 patients with end-
stage liver disease secondary to IBDI were considered for
LT. Among them, 3 died on the waiting list (from septic
and haemorrhagic complications), 8 were successfully
transplanted and 3 are still waiting for LT. End-stage liver
disease was found in 14 of 84 patients (16.6%) with IBDI
referred to our Unit. The 8 transplanted patients rep-
resent 3.6% of the 221 LTs performed at our hospital
during this period.
The clinical characteristics and outcome of the trans-
planted patients were analysed retrospectively. There were
four men and four women, and the mean age was 41 years
(24–62 yr). In 5 patients the IBDI occurred during chole-
cystectomy (3 open, 2 laparoscopic), in 2 patients during
treatment for a hydatid cyst (Figure 1), and in one patient
during open common bile duct exploration. The last case
was one of instrumental perforation of the posterior wall of
the common duct during stone removal. There was one case
of complete ligature of the right hepatic vascular pedicle
with delayed right lobe liver atrophy (Figures 3 and 4).
Several open and percutaneous procedures were per-
formed in these patients (Figure 2). However, all but one
patient had marked strictures of their repairs at the time
that LT was indicated. In one case of formalin injury to the
bile duct during operation for hydatic cysts, biliary recon-
struction was not possible because of the diffuse injury.
The mechanism and level of biliary injury (according to
Bismuth’s classification of benign biliary stricture [7]), the
reparative procedure and other characteristics of the 8
transplanted patients are described in Tables 1 and 2.
All patients had oesophageal variceal bleeding second-
ary to portal hypertension, and six received intensive endo-
scopic therapy (sclerotherapy or banding) and medical
treatment. Six patients had multiple episodes of acute
cholangitis, one case being associated with multiple liver
abscesses. Four patients had refractory ascites, two had
intractable pruritus and one patient had recurrent episodes
of spontaneous bacterial peritonitis. In patients with gastro-
intestinal bleeding and/or refractory ascitis, the possibility
of a transjugular intrahepatic portosystemic shunt (TIPS)
was considered, but this therapy was contraindicated
because of the risk of cholangitis and sepsis. LT was per-
formed electively in 7 patients and urgently in one. The
mean interval time between IDBI and inclusion on the
waiting list was 41.8 months (14–76 ms), and the mean
interval time between the last bile duct repair and inclusion
on the waiting list was 26 months (9–44 ms). The mean time
on the waiting list was 10.6 months (2–23 ms). The average
follow-up time after LT was 47.5 months (7–97 ms).
A standard technique was used for vascular reconstruc-
tion. Biliary tract reconstruction was performed with a
Roux-en-Y hepatojejunostomy, with interrupted poly-
propylene 6/0 or 7/0 sutures and extraluminal knots using
expanded field magnification glasses. Bacterial and fungal
prophylaxis was given using ceftriaxone plus ampicillin in
newly-admitted patients or vancomycin, imipenem and
fluconazole in hospitalised patients.
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Table 1. Mechanism of injury, primary biliary repair and other operations in patients transplanted for the sequelae intraoperative bile duct
injury
Case Age Set I Pro Injury mechanism Primary repair Other surgeries BC
1 62 F Lap Chole Section. Ischemia. Bi HJA Laparotomy for choleperitoneum III + RVL
Electrocoagulation Redo Bi HJA
2 42 M Lap Chole Section End to end HJA III
anastomosis T tube
3 32 M Open Chole Section End to end HJA III
anastomosis T tube PBD
4 40 F Lap Chole Electrocoagulation HJA Laparotomy for choleperitoneum III–IV
PBD & stricture dilatation
5 41 M Open Chole Section. Ischemia. End to end Choledochoplasty II
Electrocoagulation anastomosis T tube PBD & metallic stent placement
6 24 F Open Hydatic Formalin injury Laparotomy for choleperitoneum –
7 41 M Open CBDE Perforation HJA + Percutaneous drainages of AA II
hemigastrectomy PBD & stricture dilatation
8 46 F Open Hydatic Resection HJA Re-HJA III
Initial procedure (I Pro); Laparoscopic cholecystectomy (Lap Chole) or Open Cholecystectomy (Open Chole); Open Common Bile Duct Exploration (Open
CBDE), Bismuth classification of biliary injury (BC); Percutaneous biliary drainage (PBD); Right hepatic vascular lesion (RVL);Abdominal abscess (AA),
Hepaticojejuno anastomosis (HJA)
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The operative time and intraoperative blood loss in
patients transplanted for IBDI (Group I) was compared
with that of 116 adult patients undergoing LT for other rea-
sons with a full-size cadaveric liver during the same period
in our unit (Group II). Student’s t-Test was used, and
significance was established at a p value of 0.05 or less.
Results
In all eight transplanted patients a full orthotopic cadaver
graft was used, according to standard techniques. All trans-
plants were blood group compatible (7 isogroup and 1 het-
erogroup). Immunosuppressive therapy consisted of
cyclosporin, steroids and azathioprine in 4 patients and
tacrolimus with steroids in the other four.
The mean recipient hepatectomy time was 243 minutes
(140–295 min), the mean time of the anhepatic phase was
89.2 (45–135 min) and 3 patients required extra-corporeal
circulation. The mean duration of operation was 545 min-
utes (270–720 min) compared with 466 minutes (215–900
min) in group II, but the difference was not statistically sig-
nificant (p < 0.3). Mean operative blood loss was 6.5 (1–7
units) in Group I and 4.4 (0–25 units) in Group II
(p < 0.16, ns). Intraoperative accidents included a
diaphragmatic laceration in one patient and multiple
perforations of the small bowel in another, each related to
the release of intense adhesions. There were no intra-oper-
ative deaths.
Immediate postoperative complications related to the
procedure were peritonitis due to perforation of the Roux-
en-Y loop, subphrenic abscess and wound infection, in one
patient. Two patients developed mild infection of the sur-
gical wound and one inguinal lymphocele with lymphatic
fistula related to the placement of the venous line for the
veno-venous bypass. There were no complications related
to the biliary anastomosis. Four patients had acute rejection
episodes that were mild in three cases and severe in one
case. All responded to conventional therapy.
The average weight of the resected specimens was
2151 g (r 1670–2505), and the pathological diagnosis was
secondary biliary cirrhosis in five patients and secondary
sclerosing cholangitis in three patients (Figure 5).
The in-hospital mortality rate was 12.5%. One patient
died on the seventh postoperative day with autopsy evi-
dence of a bacterial pneumonia but no graft complications.
The average postoperative stay in the intensive care unit
was 6.5 days (4–10 days), and the average postoperative
stay in hospital was 19.2 days (11–37 days).
On long-term follow-up, one patient died 7 months after
the initial transplant due to rupture of a cerebral mycotic
Table 2. Laboratory data and indications for LT in patients with IBDI.
Case number Bil t/d (µmol/L) AP (U/dl) Prot (%) Clinical aspects
1 41/20.5 450 73 PHT and recurrent episodes of EVB
Refractory ascitis
2 94/73.5 1000 65 Recurrent episodes of cholangitis
3 73.5/46.2 1020 80 Recurrent episodes of cholangitis
Multiple liver abscesses
PHT with recurrent episodes of EVB
4 13.7/5.1 1600 88 PHT with recurrent episodes of EVB
5 193.2/102.6 1035 50 Recurrent episodes of cholangitis
PHT with recurrent episodes of EVB
Refractory ascitis
Intractable pruritus
6 167.6/109.4 1823 80 Recurrent episodes of cholangitis
7 229.1/153.9 1250 55 Recurrent episodes of cholangitis
PHT with recurrent episodes of EVB
Refractory ascitis
Intractable pruritus
8 76.9/61.6 1200 71 Recurrent episodes of cholangitis
PHT with recurrent episodes of EVB
Refractory ascitis
Spontaneous bacterial peritonitis
Total and direct serum bilirrubin (Bil t/d);Alkaline phosphatase U/dl (AP); Prothrombine concentration (Prot.) Esophageal variceal bleeding (EVB); Portal
hypertension (PHT).
aneurysm after retransplantation for thrombosis of the
hepatic artery. The remaining 6 patients (75%) have a very
good quality of life and normal liver function tests.
Discussion
Although technical and technological advances allow a
better solution for IBDI, the future of these patients is not
yet well defined. Many patients receive endoscopic and
percutaneous procedures as initial treatment to avoid repar-
ative surgery. The long-term results of such procedures have
not yet proved their effectiveness. Some patients present
frequent episodes of cholangitis and persistent cholestasis,
as shown by liver function tests. Persistent elevation of
serum alkaline phosphatase indicates a variable degree of
biliary obstruction, a mechanism that generates progressive
and irreversible chronic disease in 8–10% of cases [4–6, 12].
One of the most frequent causes of secondary biliary
cirrhosis (SBC) and secondary sclerosing cholangitis (SSC)
is benign stricture of the bile duct, which is generally due to
a surgical injury [13]. In a series of 44 patients reported by
Braasch, the incidence of SBC after bile duct repair for
intraoperative injuries reached 8% on long-term follow-up.
[3].
The causes of irreversible liver disease and its com-
plications such as SBC are a poor initial repair of the lesion,
multiple strictures and anastomotic obstruction with
persistent cholestasis. Cholestasis causes bilioportal and
centrilobular ectasia. To become established cirrhosis,
cholestasis must persist for a considerable period of time,
yet liver disease does not develop in all cases. This variable
behaviour could be accounted for by the complete or
incomplete nature of the biliary obstruction, by the exis-
tence of accessory biliary canals or by reperfusion with the
formation of new ducts surrounding the obstruction [14,
15]. In the one patient with injury of the formalin biliary
tree, the time from the initial lesion to the indication for
transplant was only 14 months because of recurrent
episodes of cholangitis.
Special considerations should be kept in mind concern-
ing LT in patients with end-stage liver disease secondary to
IBDI. Complications such as intractable pruritus, recurrent
life-threatening cholangitis or severe impairment of nutri-
tional status may become the main indication for LT. From
a technical standpoint there is additional risk because of
previous surgical and instrumental procedures [13].
In a series of 130 patients with IBDI, 17.7% had portal
hypertension and in all those who died in hospital (6.2%),
death resulted from the complications of portal hyperten-
sion or from liver failure and sepsis [1]. Biliary tract injuries
are frequently associated with hepatic artery and portal
vein lesions, and these factors worsen the prognosis [8, 9].
In our IBDI series, 3 patients died on the waiting list as a
consequence of intractable complications of portal hyper-
tension complications, and one patient had an injury of the
right arterial and portal pedicle which led to complete atro-
phy of that lobe [10].
We have not found any published series of patients
transplanted as a consequence of IBDI, although some
reviews mention LT as a therapeutic possibility [2]. In one
recent publication on IBDI, however, LT was not even
mentioned as an option for treatment [12]. Two case reports
have been published of patients with biliary and vascular
injury following laparoscopic cholecystectomy who required
LT [8, 9]. Likewise, many worldwide series of transplants,
SBC cases are exceptional. In Bismuth’s report of 350
patients, only three patients were transplanted for SBC,
and the cause of this complication was not described. [13].
In 1990, Moossa published a report of a series of 81
patients with IBDI including four who had been trans-
planted, all of whom died in the postoperative period. In
the discussion of this paper, Block suggests that ‘… patients
were transplanted too late, or were transplanted at a very
early stage in the development of this type of surgery’ [2].
Intractable ascites, repeated episodes of variceal bleed-
ing, repeated cholangitis, progressive jaundice, pruritus and
poor quality of life are all indicators for the need of liver
replacement [13, 16]. Early referral to transplant centres is
recommended to avoid severe malnutrition and infectious
complications before the procedure, a situation that
becomes worse with a long waiting period (three of our
patients died waiting for a liver). Treatment of malnutrition
and concomitant infections is required during this period.
Percutaneous biliary procedures are helpful in the treat-
ment of pruritus and acute cholangitis in this stage [16].
In these patients LT is technically more complex than
usual, due to intra-abdominal adhesions, sclerosis of the
hepatic pedicle, severe portal hypertension and associated
coagulopathy. Profuse bleeding may be encountered during
the hepatectomy phase, and in cases of severe portal hyper-
tension veno-venous bypass may be necessary to minimise
this bleeding. Cannulation of the portal system through the
inferior mesenteric vein is useful before dissection of the
hepatic pedicle in such cases. In our series the intraopera-
tive blood loss and total operation time were higher than in
LT for other reasons, but not significantly so.
E de Santibañes et al.
114
The five-year survival rate of LT for benign diseases
exceeds 80%, with excellent quality of life. For this reason,
we believe that the use of this procedure to treat end-stage
liver disease for IBDI will increase in the future. For opti-
mal results, LT must be performed soon after the develop-
ment of severe sequelae.
The advent of laparoscopic cholecystectomy has led to
a resurgence of IBDI. Moreover, these lesions have proved
to be more severe and complex that those caused during
open cholecystectomy. They tend to be located more prox-
imally (in association with resection of the bile duct) and
may be combined with external biliary fistulas that result in
a small-calibre bile duct at the time of initial surgical repair.
Short-term results may therefore be poor after repair, while
concomitant vascular injuries make the situation even
worse [4–6, 8, 9, 12]. All these facts lead us to suggest that
IBDI during laparoscopic cholecystectomy will result in an
increased demand for LT in the future [6].
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